RINLYGRA Trademark

Serial Number: 50004857

RINLYGRA is a trademark filed by Emerge Bioscience Pte. Ltd. on July 21, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Trademark Classes

5

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

44

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Emerge Bioscience Pte. Ltd. (9 trademarks)

133 Cecil Street
Singapore 069535 , SG

Entity Type: 24

Legal Representation

Attorney of Record

Eric R. Moran

2,283 trademarks filed View all →

Correspondence Address

Eric R. Moran McDonnell Boehnen Hulbert & Berghoff LLP

300 South Wacker Drive

31st Floor

Chicago, IL 60606

United States

Trademark Details

Filing Date

July 21, 2026

Registration Date

Not Registered

Goods & Services

Providing medical information; providing health information; providing medical information in the field of diabetes; providing health information in the field of diabetes; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services

Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin glargine; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin glargine; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin glargine; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics

Providing information in the field of scientific and medical research related to pharmaceuticals; providing information in the field of scientific and medical research related to diabetes; research and development of pharmaceuticals; research and development of pharmaceuticals in the field of diabetes